Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Overview
- Cholesterol Test
- Diabetes Test
- Blood Pressure Test
- Cancer Screening Test
- Prenatal Testing
- Vision and Hearing Screening
- Bone Density Test
- Thyroid Profile Test
- Essential Nutrients Check
- Others
Chapter 3 Market Dynamics
- Factors Affecting the Routine Health Screening Market
- Market Drivers
- Advancements in Screening Technologies
- Growing Prevalence of Chronic Diseases
- Growing Health Consciousness
- Increasing Healthcare Spending
- Market Restraints
- High Costs Associated with Routine Health Screening
- Psychological Barriers
- Lack of Awareness and Acceptability in Low and Middle Income Countries
- Market Challenges
- False Positive and False Negative Screening Test Results
- Declining Reimbursement
- Market Opportunities
- Adoption of AI in Routine Health Screening
- Expansive Opportunities in Emerging Economies
Chapter 4 Market Segmentation Analysis
- Segmentation Breakdown
- Routine Health Screening Market, by Test Type
- Cholesterol Screening
- Diabetes Screening
- Blood Pressure Test
- Cancer Screening
- Prenatal Screening
- Vision and Hearing Screening
- Bone Density Test
- Thyroid Profile Test
- Essential Nutrients Tests
- Others
- Routine Health Screening Market, by Sample Type
- Overview
- Blood-Based Sample
- Urine-Based Sample
- Imaging Sample
- Other Samples
- Routine Health Screening Market, by Technology
- Overview
- QPCR (Quantitative Polymerase Chain Reaction)
- Q-FISH (Quantitative Fluorescence In Situ Hybridization) Technology
- Immunoassays
- Medical Imaging
- STELA (Single Telomere Length Analysis)
- Other Technologies
- Geographic Breakdown
- Routine Health Screening Market, by Region
- North America
- Asia-Pacific
- Europe
- Rest of the World
Chapter 5 Emerging and Upcoming Technologies in the Market
- Introduction
- Emerging and Upcoming Technologies
- Deep Phenotyping Technologies
- Digital Health Interventions
- Digital Precision Medicine
- Wearable Devices and Remote Monitoring
- Multicancer Detection (MCDs) Assays
- Artificial Intelligence in Routine Health Screening
- 5G-Enabled Devices
- Genetics Testing
- Technological Concerns in the Routine Health Screening Market
- Efficacy Data
- Data Privacy
- Regulatory Landscape
- Supply Chain Challenges
- Recent Developments
Chapter 6 ESG Development
- Introduction
- Sustainability in Routine Health Screening Industry
- WHO Global Action Plan
- Publisher Viewpoint
Chapter 7 Competitive Landscape
- Mergers, Acquisitions and Collaborations
- Manufacturer and Service Provider Market Share Analysis
- Strategic Alliances
List of Tables
Summary Table: Global Routine Health Screening Market, by Test Type, Through 2029
Table 1: Projected Number of Adults 50 Years and Older with More than One Chronic Condition in the United States, 2020-2050
Table 2: Estimated False Positive Probability of One Screening Occasion
Table 3: Preventive Health Screenings, by Age
Table 4: Global Routine Health Screening Market, by Test Type, Through 2029
Table 5: Global Cholesterol Screening Market in Routine Health Screening, by Region, Through 2029
Table 6: Global Diabetes Screening Market in Routine Health Screening, by Region, Through 2029
Table 7: Global Blood Pressure Screening Market in Routine Health Screening, by Region, Through 2029
Table 8: Global Cancer Screening Market in Routine Health Screening, by Region, Through 2029
Table 9: Chance for Down Syndrome, by Age
Table 10: Global Prenatal Screening Market in Routine Health Screening, by Region, Through 2029
Table 11: Global Vision and Hearing Screening Market in Routine Health Screening, by Region, Through 2029
Table 12: Global Bone Density Test Market in Routine Health Screening, by Region, Through 2029
Table 13: Global Thyroid Profile Test Market in Routine Health Screening, by Region, Through 2029
Table 14: Global Essential Nutrients Test Market in Routine Health Screening, by Region, Through 2029
Table 15: Global Other Screening Tests Market in Routine Health Screening, by Region, Through 2029
Table 16: Global Routine Health Screening Market, by Sample, Through 2029
Table 17: Global Routine Health Screening Market Based on Blood Sample, by Region, Through 2029
Table 18: Global Routine Health Screening Market Based on Urine Sample, by Region, Through 2029
Table 19: Global Routine Health Screening Market Based on Imaging Sample, by Region, Through 2029
Table 20: Global Routine Health Screening Market based on Other Types of Sample, by Region, Through 2029
Table 21: Global Routine Health Screening Market, by Technology, Through 2029
Table 22: Global Routine Health Screening Market based on Quantitative Polymerase Chain Reaction (QPCR) Technology, by Region, Through 2029
Table 23: Global Routine Health Screening Market based on Q-FISH (Quantitative Fluorescence in Situ Hybridization) Technology, by Region, Through 2029
Table 24: Global Routine Health Screening Market Based on Immunoassays Technology, by Region, Through 2029
Table 25: Global Routine Health Screening Market based on Medical Imaging Technology, by Region, Through 2029
Table 26: Global Routine Health Screening Market based on STELA (Single Telomere Length Analysis), Technology, by Region, Through 2029
Table 27: Global Routine Health Screening Market based on Other Technologies, by Region, Through 2029
Table 28: Global Routine Health Screening Market, by Region, Through 2029
Table 29: North American Routine Health Screening Market, by Country, Through 2029
Table 30: APAC Routine Health Screening Market, by Country, Through 2029
Table 31: European Routine Health Screening Market, by Country, Through 2029
Table 32: ESG Highlights by Major Players, 2023
Table 33: ESG Rankings for Major Routine Health Screening Companies, 2023
Table 34: Mergers and Acquisitions: Routine Health Screening Tests Manufacturers and Service Providers, 2021-2024
Table 35: Major Strategic Alliances in the Routine Health Screening Industry, 2021-2024
Table 36: Information Sources in this Report
Table 37: Major Abbreviations Used in This Report
Table 38: ARUP Laboratories: Company Snapshot
Table 39: ARUP Laboratories: Product Portfolio
Table 40: ARUP Laboratories: News/Key Developments, 2021-2024
Table 41: Cerba Healthcare: Company Snapshot
Table 42: Cerba Healthcare: Product Portfolio
Table 43: Cereba Healthcare: News/Key Developments, 2021-2023
Table 44: Eurofins Scientific: Company Snapshot
Table 45: Eurofins Scientific: Financial Performance, FY 2022 and 2023
Table 46: Eurofins Scientific: Product Portfolio
Table 47: Eurofins Scientific: News/Key Developments, 2022
Table 48: Exact Science Corp.: Company Snapshot
Table 49: Exact Science Corp.: Financial Performance, FY 2022 and 2023
Table 50: Exact Science Corp.: Product Portfolio
Table 51: Exact Science Corp.: News/Key Developments, 2021-2024
Table 52: OPKO Health Inc.: Company Snapshot
Table 53: OPKO Health Inc.: Financial Performance, FY 2022 and 2023
Table 54: OPKO Health Inc.: Product Portfolio
Table 55: OPKO Health Inc.: News/Key Developments, 2021-2023
Table 56: Laboratory Corporation of America Holdings: Company Snapshot
Table 57: Laboratory Corporation of America Holdings: Financial Performance, FY 2022 and 2023
Table 58: Laboratory Corporation of America Holdings: Product Portfolio
Table 59: Laboratory Corporation of America Holdings: News/Key Developments, 2022-2024
Table 60: Natera Inc.: Company Snapshot
Table 61: Natera Inc: Financial Performance, FY 2022 and 2023
Table 62: Natera Inc.: Product Portfolio
Table 63: Natera Inc.: News/Key Developments, 2024
Table 64: Quest Diagnostic Inc.: Company Snapshot
Table 65: Quest Diagnostic Inc.: Financial Performance, FY 2022 and 2023
Table 66: Quest Diagnostic Inc.: Product Portfolio
Table 67: Quest Diagnostic Inc.: News/Key Developments, 2021-2024
Table 68: Sonic Healthcare Ltd.: Company Snapshot
Table 69: Sonic Healthcare Ltd.: Financial Performance FY 2022 and 2023
Table 70: Sonic Healthcare Ltd.: Product Portfolio
Table 71: Sonic Healthcare Ltd.: News/Key Developments, 2022
Table 72: SYNLAB AG: Company Snapshot
Table 73: SYNLAB AG: Company Financials, FY 2022 and 2023
Table 74: SYNLAB AG: Product Portfolio
Table 75: SYNLAB AG: News/Key Developments, 2022
List of Figures
Summary Figure: Global Routine Health Screening Market, by Test Type, 2021-2029
Figure 1: Differentiating Cancer Screening from Early Diagnosis Based on Symptom Onset
Figure 2: Role of AI-Based Approaches in Various Themes of Healthcare Research
Figure 3: Detection and Intervention through Cancer Screening
Figure 4: Global Routine Health Screening Market Dynamics
Figure 5: 10 Common Chronic Conditions in Adults 65+, U.S., 2024
Figure 6: Percentage of Visits to Health Centers by Primary Reason for the Visit: United States, 2020
Figure 7: Per Capita Healthcare Expenditure for Few Top Countries, 2021
Figure 8: Global Routine Health Screening Market Shares, by Test Type, 2023
Figure 9: Global Cholesterol Screening Market in Routine Health Screening, by Region, 2021-2029
Figure 10: Global Diabetes Screening Market in Routine Health Screening, by Region, 2021-2029
Figure 11: Global Diabetes Screening Market in Routine Health Screening, by Region, 2021-2029
Figure 12: Global Cancer Screening Market in Routine Health Screening, by Region, 2021-2029
Figure 13: Global Prenatal Screening Market in Routine Health Screening, by Region, 2021-2029
Figure 14: Global Vision and Hearing Screening Market in Routine Health Screening, by Region, 2021-2029
Figure 15: Global Bone Density Test Market in Routine Health Screening, by Region, 2021-2029
Figure 16: Global Thyroid Profile Test Market in Routine Health Screening, by Region, 2021-2029
Figure 17: Global Essential Nutrients Test Market in Routine Health Screening, by Region, 2021-2029
Figure 18: Global Other Screening Tests Market in Routine Health Screening, by Region, 202-2029
Figure 19: Global Routine Health Screening Market, by Sample, 2021-2029
Figure 20: Global Routine Health Screening Market Shares, by Sample, 2023
Figure 21: Diagnostic Significance of Urinary Markers and Metabolites for Disease
Figure 22: Global Routine Health Screening Market, by Technology, 2021-2029
Figure 23: Global Routine Health Screening Market, by Region, 2021-2029
Figure 24: Global Routine Health Screening Market Shares, by Region, 2023
Figure 25: North American Routine Health Screening Market Shares, by Country, 2023
Figure 26: APAC Routine Health Screening Market Shares, by Country, 2023
Figure 27: European Routine Health Screening Market Shares, by Country, 2023
Figure 28: Global Routine Health Screening Market Shares, by Key Manufacturers and Service Providers, 2023
Figure 29: Eurofins Scientific: Revenue Shares, by Business Unit, FY 2023
Figure 30: Eurofins Scientific: Revenue Shares, by Country/Region, FY 2023
Figure 31: Exact Science Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 32: Exact Science Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 33: OPKO Health Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 34: OPKO Health Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 35: Laboratory Corporation of America Holdings: Revenue Shares, by Business Unit, FY 2023
Figure 36: Laboratory Corporation of America Holdings: Revenue Shares, by Country/Region, FY 2022
Figure 37: Natera Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 38: Natera Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 39: Quest Diagnostic Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 40: Sonic Healthcare Ltd.: Revenue Shares, by Business Unit, FY 2023
Figure 41: Sonic Healthcare Ltd.: Revenue Shares, by Country/Region, FY 2023
Figure 42: SYNLAB AG: Revenue Shares, by Business Unit, FY 2023
Figure 43: SYNLAB AG.: Revenue Shares, by Country/Region, FY 2023
